Contrave ER 8-90 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F9KU5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,013
Award facts
- Contract value 100% obligated
- $20,012.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 12, 2026, provides Contrave ER 8-90 mg tablets (120 count) to the Defense Logistics Agency through a firm fixed-price contract valued at approximately $20K. The award was issued to AmerisourceBergen Drug Corp, the Corporate Office division of Cencora, Inc., with performance to be completed by January 13, 2026 at the company's Conshohocken, Pennsylvania headquarters. This contract represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supplies to military healthcare systems globally through December 2026.
AmerisourceBergen's federal contract portfolio demonstrates its critical role as a pharmaceutical distributor supporting Department of Defense and military healthcare needs, supplying an extensive range of medications across multiple therapeutic domains including specialty pharmaceuticals, vaccines, and medical devices. The company's competitively awarded delivery orders under the DLA prime IDC reflect its capability to efficiently fulfill government procurement requirements for essential medical commodities needed by military treatment facilities and veteran healthcare programs. This particular delivery order for Contrave, an FDA-approved prescription medication used in weight management, exemplifies the diverse therapeutic categories the contractor supplies through its relationship with DLA.
Quick answers
Who was awarded contract SPE2DR26F9KU5?
SPE2DR26F9KU5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9KU5 worth?
The government has obligated $20,013 on SPE2DR26F9KU5.
Is contract SPE2DR26F9KU5 an order under another contract?
Yes. SPE2DR26F9KU5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KU5 competed?
The extent of competition for SPE2DR26F9KU5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award